C20H13ClF3N3O4
Neat
451.79
Room Temperature
1012058-78-4; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)picolinic acid; Sorafenib Hydroxydemethylamine; Sorafenib metabolite M6; 4-(4-((4-Chloro-3-(trifluoromethyl)phenyl)carbamoylamino)phenoxy)pyridine-2-carboxylic acid; O9ZAV58U4C; MFCD26954590; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]pyridine-2-carboxylic acid; 2-Pyridinecarboxylic acid, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-; 2-Pyridinecarboxylic acid and 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-; UNII-O9ZAV58U4C; Sorafenib Impurity 16; C20H13ClF3N3O4; SCHEMBL3408499; SCHEMBL29793192; GEO-00823; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido) phenoxy)picolinic acid; AKOS024573831; CCG-355957; BS-46100
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]pyridine-2-carboxylic acid
InChI=1S/C20H13ClF3N3O4/c21-16-6-3-12(9-15(16)20(22,23)24)27-19(30)26-11-1-4-13(5-2-11)31-14-7-8-25-17(10-14)18(28)29/h1-10H,(H,28,29)(H2,26,27,30)